Details of the Drug Inactive Ingredient (DIG)
General Information of DIG (ID: E0HR5F) | |||||
---|---|---|---|---|---|
DIG Name |
Soybean lecithin
|
||||
DIG Function |
Other agent
|
||||
Full List of Active Pharmaceutical Ingredients (APIs) Co-administrated with This DIG | ||||||
---|---|---|---|---|---|---|
ICD Disease Classification 01 | Infectious/parasitic disease | Click to Show/Hide | ||||
Azithromycin
|
API Info |
Congenital syphilis [ICD-11: 1A60]
|
[1] | |||
Amantadine
|
API Info |
Influenza virus infection [ICD-11: 1E30]
|
[2] | |||
Tetracycline
|
API Info |
Spotted fever [ICD-11: 1C31]
|
[3] | |||
Maraviroc
|
API Info |
Human immunodeficiency virus infection [ICD-11: 1C60]
|
[4] | |||
Zidovudine
|
API Info |
Human immunodeficiency virus infection [ICD-11: 1C60]
|
[5] | |||
Ganciclovir
|
API Info |
Cytomegalovirus infection [ICD-11: 1D82]
|
[6] | |||
Fidaxomicin
|
API Info |
Clostridium difficile infection [ICD-11: 1A04]
|
[7] | |||
Moxifloxacin
|
API Info |
Streptococcus bacterial infection [ICD-11: 1C41]
|
[8] | |||
ICD Disease Classification 02 | Benign/in-situ/malignant neoplasm | Click to Show/Hide | ||||
Nicotinic acid
|
API Info |
Lung cancer [ICD-11: 2C25]
|
[9] | |||
Regorafenib
|
API Info |
Colon cancer [ICD-11: 2B90]
|
[10] | |||
ICD Disease Classification 05 | Endocrine/nutritional/metabolic disease | Click to Show/Hide | ||||
Fenofibrate
|
API Info |
Hypertriglyceridaemia [ICD-11: 5C80]
|
[11] | |||
Atorvastatin
|
API Info |
Hyperlipidaemia [ICD-11: 5C8Z]
|
[12] | |||
Paricalcitol
|
API Info |
Hyperparathyroidism [ICD-11: 5A51]
|
[13] | |||
Metformin
|
API Info |
Diabetes mellitus [ICD-11: 5A10]
|
[14] | |||
Omega-3 acid ethyl ester
|
API Info |
Hypertriglyceridaemia [ICD-11: 5C80]
|
[15] | |||
Ergocalciferol
|
API Info |
Hypoparathyroidism [ICD-11: 5A50]
|
[16] | |||
Fluvastatin
|
API Info |
Hypertriglyceridaemia [ICD-11: 5C80]
|
[17] | |||
ICD Disease Classification 06 | Mental/behavioural/neurodevelopmental disorder | Click to Show/Hide | ||||
Bupropion
|
API Info |
Nicotine dependence [ICD-11: 6C4A]
|
[18] | |||
Fluoxetine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[19] | |||
Venlafaxine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[20] | |||
Amitriptyline
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[21] | |||
Methylphenidate
|
API Info |
Attention deficit hyperactivity disorder [ICD-11: 6A05]
|
[22] | |||
Paroxetine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[23] | |||
Quetiapine
|
API Info |
Schizophrenia [ICD-11: 6A20]
|
[24] | |||
Cyclobenzaprine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[25] | |||
Fluphenazine
|
API Info |
Schizophrenia [ICD-11: 6A20]
|
[26] | |||
Chlordiazepoxide
|
API Info |
Anxiety disorder [ICD-11: 6B00]
|
[27] | |||
ICD Disease Classification 08 | Nervous system disease | Click to Show/Hide | ||||
Gabapentin
|
API Info |
Focal seizure [ICD-11: 8A68]
|
[28] | |||
Valproic acid
|
API Info |
Epilepsy [ICD-11: 8A60]
|
[29] | |||
Pramipexole
|
API Info |
Parkinsonism [ICD-11: 8A00]
|
[30] | |||
Ropinirole
|
API Info |
Parkinsonism [ICD-11: 8A00]
|
[31] | |||
Levetiracetam
|
API Info |
Focal seizure [ICD-11: 8A68]
|
[32] | |||
Topiramate
|
API Info |
Focal seizure [ICD-11: 8A68]
|
[33] | |||
Oxcarbazepine
|
API Info |
Epilepsy [ICD-11: 8A60]
|
[34] | |||
Donepezil
|
API Info |
Alzheimer disease [ICD-11: 8A20]
|
[35] | |||
Eletriptan
|
API Info |
Migraine [ICD-11: 8A80]
|
[36] | |||
Lacosamide
|
API Info |
Epilepsy [ICD-11: 8A60]
|
[37] | |||
Ezogabine
|
API Info |
Epilepsy [ICD-11: 8A60]
|
[38] | |||
ICD Disease Classification 10 | Ear/mastoid process disease | Click to Show/Hide | ||||
Diphenhydramine
|
API Info |
Meniere disease [ICD-11: AB31]
|
[39] | |||
Amoxicillin
|
API Info |
Acute otitis media [ICD-11: AB00]
|
[40] | |||
ICD Disease Classification 11 | Circulatory system disease | Click to Show/Hide | ||||
Nifedipine
|
API Info |
Angina pectoris [ICD-11: BA40]
|
[41] | |||
Propafenone
|
API Info |
Ventricular tachyarrhythmia [ICD-11: BC71]
|
[42] | |||
Benazepril
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[43] | |||
Dipyridamole
|
API Info |
Atherosclerosis [ICD-11: BA80]
|
[44] | |||
Ambrisentan
|
API Info |
Pulmonary hypertension [ICD-11: BB01]
|
[45] | |||
Quinapril
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[46] | |||
Macitentan
|
API Info |
Pulmonary hypertension [ICD-11: BB01]
|
[47] | |||
ICD Disease Classification 12 | Respiratory system disease | Click to Show/Hide | ||||
Montelukast
|
API Info |
Asthma [ICD-11: CA23]
|
[48] | |||
Guaifenesin
|
API Info |
Asthma [ICD-11: CA23]
|
[49] | |||
Budesonide
|
API Info |
Allergic rhinitis [ICD-11: CA08]
|
[50] | |||
ICD Disease Classification 13 | Digestive system disease | Click to Show/Hide | ||||
Pantoprazole
|
API Info |
Gastro-oesophageal reflux disease [ICD-11: DA22]
|
[51] | |||
Simethicone
|
API Info |
Irritable bowel syndrome [ICD-11: DD91]
|
[52] | |||
Mycophenolate mofetil
|
API Info |
Crohn disease [ICD-11: DD70]
|
[53] | |||
Cimetidine
|
API Info |
Duodenal ulcer [ICD-11: DA63]
|
[54] | |||
Rabeprazole
|
API Info |
Gastro-oesophageal reflux disease [ICD-11: DA22]
|
[55] | |||
Famotidine
|
API Info |
Peptic ulcer [ICD-11: DA61]
|
[56] | |||
Trimethobenzamide
|
API Info |
Functional nausea/vomiting [ICD-11: DD90]
|
[57] | |||
Nitazoxanide
|
API Info |
Irritable bowel syndrome [ICD-11: DD91]
|
[58] | |||
ICD Disease Classification 14 | Skin disease | Click to Show/Hide | ||||
Pseudoephedrine
|
API Info |
Erythema multiforme [ICD-11: EB12]
|
[59] | |||
Tretinoin
|
API Info |
Acne vulgaris [ICD-11: ED80]
|
[60] | |||
ICD Disease Classification 15 | Musculoskeletal/connective-tissue disease | Click to Show/Hide | ||||
Indomethacin
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[61] | |||
Phenylephrine
|
API Info |
Juvenile rheumatoid arthritis [ICD-11: FA24]
|
[62] | |||
Piroxicam
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[63] | |||
ICD Disease Classification 16 | Genitourinary system disease | Click to Show/Hide | ||||
Ibuprofen
|
API Info |
Dysmenorrhea [ICD-11: GA34]
|
[64] | |||
Dutasteride
|
API Info |
Prostatic hyperplasia [ICD-11: GA90]
|
[65] | |||
Progesterone
|
API Info |
Endometrial hyperplasia [ICD-11: GA16]
|
[66] | |||
Sevelamer
|
API Info |
Chronic kidney disease [ICD-11: GB61]
|
[67] | |||
Fesoterodine
|
API Info |
Overactive bladder [ICD-11: GC50]
|
[68] | |||
Full List of Biological Targets of DIG (DBTs) Regulated by This DIG | ||||||
---|---|---|---|---|---|---|
Oxidoreductase (ORase) | ||||||
DBT Name: Albendazole monooxygenase (CYP3A4) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 6.61 mg.mL-1 (tested by experiment) | [69] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | CP3A4_HUMAN | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.